CTAG1B

Cancer/testis antigen 1B
Identifiers
Symbols	CTAG1B ; CTAG; CTAG1; ESO1; LAGE-2; LAGE2B; NY-ESO-1; CAMEL; ESO2; LAGE-1; LAGE-2b; MGC138724; MGC3803; LAGE2A
External IDs	Template:OMIM5 HomoloGene: 37469
Gene ontology Molecular function Template:GNF GO Cellular component Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Biological process Template:GNF GO
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

Cancer/testis antigen 1B, also known as CTAG1B, is a human gene.

Further reading

• Scanlan MJ, Gure AO, Jungbluth AA; et al. (2003). "Cancer/testis antigens: an expanding family of targets for cancer immunotherapy". Immunol. Rev. 188: 22–32. PMID 12445278.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Chen YT, Scanlan MJ, Sahin U; et al. (1997). "A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening". Proc. Natl. Acad. Sci. U.S.A. 94 (5): 1914–8. PMID 9050879.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Chen YT, Boyer AD, Viars CS; et al. (1998). "Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28". Cytogenet. Cell Genet. 79 (3–4): 237–40. PMID 9605863.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Lethé B, Lucas S, Michaux L; et al. (1998). "LAGE-1, a new gene with tumor specificity". Int. J. Cancer. 76 (6): 903–8. PMID 9626360.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Wang RF, Johnston SL, Zeng G; et al. (1998). "A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames". J. Immunol. 161 (7): 3598–606. PMID 9759882.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• De Smet C, Lurquin C, Lethé B; et al. (1999). "DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter". Mol. Cell. Biol. 19 (11): 7327–35. PMID 10523621.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Schultz-Thater E, Noppen C, Gudat F; et al. (2000). "NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens". Br. J. Cancer. 83 (2): 204–8. doi:10.1054/bjoc.2000.1251. PMID 10901371.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Rimoldi D, Rubio-Godoy V, Dutoit V; et al. (2001). "Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma". J. Immunol. 165 (12): 7253–61. PMID 11120859.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Simpson JC, Wellenreuther R, Poustka A; et al. (2001). "Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing". EMBO Rep. 1 (3): 287–92. doi:10.1093/embo-reports/kvd058. PMID 11256614.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Jungbluth AA, Chen YT, Stockert E; et al. (2001). "Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues". Int. J. Cancer. 92 (6): 856–60. doi:10.1002/ijc.1282. PMID 11351307.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Goydos JS, Patel M, Shih W (2001). "NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma". J. Surg. Res. 98 (2): 76–80. doi:10.1006/jsre.2001.6148. PMID 11397121.CS1 maint: Multiple names: authors list (link)
• Aradhya S, Bardaro T, Galgóczy P; et al. (2002). "Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes". Hum. Mol. Genet. 10 (22): 2557–67. PMID 11709543.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Zarour HM, Maillere B, Brusic V; et al. (2002). "NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells". Cancer Res. 62 (1): 213–8. PMID 11782380.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Satie AP, Rajpert-De Meyts E, Spagnoli GC; et al. (2002). "The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ". Lab. Invest. 82 (6): 775–80. PMID 12065688.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Nagata Y, Ono S, Matsuo M; et al. (2002). "Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations". Proc. Natl. Acad. Sci. U.S.A. 99 (16): 10629–34. doi:10.1073/pnas.112331099. PMID 12138174.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Resnick MB, Sabo E, Kondratev S; et al. (2002). "Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas". Int. J. Cancer. 101 (2): 190–5. doi:10.1002/ijc.10585. PMID 12209997.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Peng LP, Liu HY, Ran YL; et al. (2003). "[Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning]". Ai Zheng. 21 (5): 469–72. PMID 12452034.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Gnjatic S, Atanackovic D, Jäger E; et al. (2003). "Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses". Proc. Natl. Acad. Sci. U.S.A. 100 (15): 8862–7. doi:10.1073/pnas.1133324100. PMID 12853579.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)